Development of glycoproteome platforms for potential cancer biomarkers screening.
Identification of immunodominant epitope in allergic disease.
Analyzing protein-protein interactions by affinity-based proteomics in cancer cell.
Using proteomic approach to investigate the possible role of microRNA 21 in cancer cell.
Discovery of potential drug-interacting protein candidates with chemical proteomics and elucidating drug-acting mechanisms through functional assays to offer well-founded bases for drug development.